Pharma

Your Article Summary

See Latest Articles

Abbott to Acquire Solvay Pharmaceuticals for $6.6 Billion
Pharmaceutical Technology, 10/14/09

Arnum PV – Abbott Laboratories (Abbott Park, IL) agreed to acquire the pharmaceutical business of the Solvay Group (Brussels, Belgium) for EUR 4.5 billion ($6.6 billion) in cash, according to an Abbott press release. The transaction also includes payments of up to EUR 300 million ($437 million) if certain sales milestones are met between 2011 and 2013. Abbott will also assume certain liabilities, mainly pensions, valued at EUR 400 million ($583 million), according to a Solvay press release.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Pre-Budget Report response - GSK comments on patent box
GlaxoSmithKline, 12/11/09

Report: Acquisition Activity Down
HealthDataManagement, 12/08/09

Genzyme Provides Update on Cerezyme Supply and 2009 Financial Information
Genzyme, 12/07/09

 See all of Financial Reports